Used in research settings as a selective inhibitor of the enzyme diacylglycerol acyltransferase 1 (DGAT1), which plays a role in triglyceride synthesis. It is primarily utilized to study lipid metabolism and energy homeostasis in cellular and animal models. Its application supports investigations into metabolic disorders such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). Due to its high selectivity and potency, it serves as a tool compound for validating DGAT1 as a therapeutic target. Not intended for clinical use or human consumption.